XML 73 R49.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS' EQUITY - EQUITY PLANS (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Feb. 29, 2020
Jan. 31, 2019
Oct. 31, 2018
May 15, 2018
STOCKHOLDERS' EQUITY              
Common stock, shares reserved for future issuance (in shares) 45,395,620            
Aggregate Intrinsic Value - Options Outstanding              
Closing stock price (in dollars per share) $ 1.36            
Total pretax intrinsic value of stock options exercised (in dollars) $ 80,000 $ 8,812,000 $ 15,000        
Cash received from exercise of options (in dollars) $ 163,000 $ 6,929,000 $ 18,000        
Number of Shares - Options Outstanding              
Options exercisable at the end of the period (in shares) 19,915,713 16,464,746 17,249,032        
Weighted Average Exercise Price Per Share - Options Outstanding              
Options exercisable at the end of the period (in dollars per share) $ 2.86 $ 3.13 $ 3.03        
2002 Plan              
STOCKHOLDERS' EQUITY              
Vesting period of options 4 years            
Exercise price as a percentage of fair market value 100.00%            
2002 Plan | Maximum              
STOCKHOLDERS' EQUITY              
Expiration term of options from date of grant 10 years            
2011 Plan              
STOCKHOLDERS' EQUITY              
Vesting period of options 4 years            
2011 Plan | Restricted stock awards              
STOCKHOLDERS' EQUITY              
Shares issued (in shares)     72,066        
Weighted Average Grant Date Fair Value Per Share              
Granted (in dollars per share)     $ 2.20        
Other disclosures              
Total fair value of restricted stock that vested     $ 159,000        
2011 Plan | Maximum              
STOCKHOLDERS' EQUITY              
Expiration term of options from date of grant 10 years            
2018 Plan              
STOCKHOLDERS' EQUITY              
Vesting period of options 4 years            
Common stock, shares reserved for future issuance (in shares)             10,000,000
Minimum percentage of ownership required for granting options at least 110% of fair market value of common stock 10.00%            
Minimum exercise price as a percentage of fair market value for employees having more than 10 % outstanding common stock 110.00%            
Maximum expiration term of options granted to employees having more than 10 % outstanding common stock 5 years            
2018 Plan | First Director Option              
STOCKHOLDERS' EQUITY              
Vesting period of options 3 years            
Options to be granted to purchase shares upon appointment (shares) 120,000            
2018 Plan | Subsequent Director Option              
STOCKHOLDERS' EQUITY              
Options to be granted to purchase shares (in shares) 70,000            
2018 Plan | Restricted stock awards              
STOCKHOLDERS' EQUITY              
Shares issued (in shares)   73,980          
Weighted Average Grant Date Fair Value Per Share              
Granted (in dollars per share)   $ 1.91          
Other disclosures              
Total fair value of restricted stock that vested   $ 141,000          
2018 Plan | Maximum              
STOCKHOLDERS' EQUITY              
Expiration term of options from date of grant 10 years            
2006 Directors Plan | First Director Option              
STOCKHOLDERS' EQUITY              
Vesting period of options 3 years            
2006 Directors Plan | Subsequent Director Option              
STOCKHOLDERS' EQUITY              
Vesting period of options 1 year            
2006 Directors Plan | Maximum              
STOCKHOLDERS' EQUITY              
Expiration term of options from date of grant 10 years            
2018 Inducement Award Plan              
STOCKHOLDERS' EQUITY              
Common stock, shares reserved for future issuance (in shares)   3,000,000     8,000,000    
2018 Inducement Award Plan | Subsequent Event              
STOCKHOLDERS' EQUITY              
Common stock, shares reserved for future issuance (in shares)       9,300,000      
Directors’ Market Value Stock Purchase Plan              
STOCKHOLDERS' EQUITY              
Common stock, shares reserved for future issuance (in shares)           1,000,000  
Directors’ Market Value Stock Purchase Plan | Restricted stock awards              
STOCKHOLDERS' EQUITY              
Shares issued (in shares) 29,150            
Weighted Average Grant Date Fair Value Per Share              
Granted (in dollars per share) $ 1.50            
Other disclosures              
Total fair value of restricted stock that vested $ 44,000